Status: Not yet recruiting
A Phase 1 Clinical Study in Healthy Participants
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered BW-41012 in Healthy Participants
Participants needed: 40
Trial details
Phase: Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: Shanghai Argo Biopharmaceutical Co., Ltd.Updated: May 13, 2026Locations: 1
Eligibility criteria
Must have given written informed consent and be able to comply with all study re... [+6]
Any clinically significant chronic medical condition or clinically significant a... [+16]